• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,944.90
    417.55 (+0.75%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 109.09(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sanjivani Paranteral Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 6710.0
  • ISIN : INE860D01013
224.85 -5 (-2.26%)
  • As on 17 Jun 2025 (EOD)

  • Today’s Low

    214.50

  • Today’s High

    231.85

  • Open

    231.00

  • Perv Close

    230.05

  • 52W Low

    171.50

  • 52W High

    396.95

Key Indicators

  • P/E(TTM)

    32.97

  • Mar.Cap (₹Cr.)

    267.16

  • Div & Yield %

    0.22

  • Book Value(₹)

    31.98

  • Debt-Equity Ratio

    -2.26

  • AGM Date

    16-Jun-2025

  • EPS

    6.82

  • P/E Ratio

    32.97

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    267.16

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    11.88

  • BV (₹)

    32.00

  • Sales( ₹ in Cr.)

    70.10

  • NP (in Cr.)

    8.10

  • NP Var(%)

    31.0

  • Div%

    5.0

  • CPS (₹)

    7.30

  • EPS (₹)

    6.80

  • Traded Value (₹ in Lakhs)

    267.16

  • 52 Week High

    396.95

  • 52 Week Low

    171.50

  • Price BSE

    225.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    267.16

  • P/C Ratio

    30.60

  • P/E Ratio

    33.00

  • Price Vs.BV

    6.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 58.95 41.47 30.61 25.10 16.36 25.09
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 58.95 41.47 30.61 25.10 16.36 25.09
Other Income 0.52 0.55 0.24 0.26 0.25 0.96
Stock Adjustments 5.89 1.28 0.35 -0.67 0.86 -0.47
Total Income 65.36 43.30 31.20 24.69 17.47 25.58
EXPENDITURE :            
Raw Materials 34.37 19.84 12.66 14.14 9.93 14.60
Power and Fuel Cost 1.14 1.10 0.98 0.78 0.58 0.73
Employee Cost 3.74 2.91 2.73 2.13 2.25 2.37
Other Manufacturing Expenses 3.24 2.19 1.98 1.08 0.70 0.72
Selling and Administration Expenses 9.45 5.32 7.22 2.91 2.60 2.76
Miscellaneous Expenses 0.12 -0.23 -0.33 1.25 1.48 5.20
Employee Benefit Expenses 3.74 2.91 2.73 2.13 2.25 2.37
Less: Preoperative Expenditure -4.54 -5.98 0.00 0.00 0.00 0.00
Total Expenses 56.60 37.11 25.24 22.30 17.55 26.38
Operating Profit 8.75 6.19 5.97 2.40 -0.08 -0.80
Interest 0.25 0.36 0.21 0.13 0.66 0.33
Gross Profit 8.50 5.83 5.76 2.27 -0.74 -1.13
Depreciation 0.93 0.89 0.88 0.86 1.07 1.17
Profit Before Tax 7.57 4.94 4.88 1.41 -1.81 -2.30
Current Tax 1.36 1.04 0.00 0.00 -0.10 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.05 -0.61 0.03 -0.01 0.00 -0.23
Reported Net Profit 6.17 4.51 4.85 1.42 -1.71 -2.07
Extraordinary Items 0.00 -0.01 0.00 0.00 0.00 0.00
Adjusted Net Profit 6.17 4.52 4.85 1.42 -1.71 -2.07
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -57.05 -61.56 -66.41 -67.83 -66.12 -64.05
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -50.89 -57.05 -61.56 -66.41 -67.83 -66.12
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.28 4.51 4.85 1.67 -2.90 0.00
Earnings Per Share(Adj)-Unit Curr 5.28 4.51 4.85 1.67 -2.90 0.00
Book Value 22.14 -3.07 -7.58 -52.83 -82.93 -80.03
Book Value(Adj)-Unit Curr 22.14 -3.07 -7.58 -52.83 -82.93 -80.03

Shareholding Pattern

  • Promoter Group

    28.87%

  • Public Share Holding

    71.13%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,430,455 28.87 3,430,455 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,430,455 28.87 3,430,455 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 600,000 5.05 600,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 130,802 1.10 130,802 1
Sub total 730,802 6.15 730,802 2
2] Non Institution
Bodies Corporate 975,603 8.21 975,603 52
Clearing Members 165 0.00 165 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 70,199 0.59 69,699 94
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 315,173 2.65 315,173 148
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,410,476 28.70 3,410,476 34
Individuals holding nominal share capital up to Rs. 1 lakh 2,819,630 23.73 2,761,340 6,104
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 604 0.01 604 2
Others 0 0.00 0 0
Sub Total 7,720,437 64.98 7,661,647 6,443
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,881,694 100.00 11,822,904 6,447

Company Background

Sanjivani Paranteral LtdPharmaceuticals - Indian - Formulations

  • Sanjivani Paranteral Ltd
  • BSE Code : 6710.0
  • ISIN : INE860D01013

  • Incorporation Year

    1994

  • Registered Office

    205 P N Khotari Indl Estate
    LBS Marg Bhandup (West), Mumbai,
    Maharashtra-400078

  • Telephone

    91-22-67290900

  • FAX

    91-22-67290930

  • Chairman

    Ashwin Khemka

  • Managing Director

    Ashwin Khemka

  • Company Secretary

  • Auditor

    R B Gohil & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Sanjivani Paranteral Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sanjiv.Parant. 224.85 54.93 54.41 32.97 11.43
Abbott India 31,658.15 6,097.18 5,848.91 47.56 44.71
Astrazeneca Phar 10,204.20 1,330.33 1,295.53 220.39 33.26
P & G Health Ltd 5,907.60 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,366.50 3,866.05 3,723.49 62.06 58.72
Cipla 1,526.90 17,645.00 16,574.34 23.91 20.10
Amrutanjan Healt 700.10 437.58 421.23 39.82 20.84
Guj. Themis Bio. 349.55 174.19 169.82 78.02 44.82
Fermenta Biotec. 341.00 315.24 307.09 14.85 4.10
Bliss GVS Pharma 147.30 638.96 605.46 22.49 11.19
Ambalal Sarabhai 36.91 11.70 3.81 34.18 1.92